. Author manuscript; available in PMC: 2014 Aug 1.

Published in final edited form as: Nat Chem Biol. 2013 Dec 22;10(2):113–121. doi: 10.1038/nchembio.1429

Table 1.

Hepatic lipid levels in WWL113-treated mice

	db/db 14 days	wt 4 hr

	WWL113/control	WWL113/control
monoacylglycerols (MAG)
C16:0 MAG	0.6	0.8
C18:0 MAG	0.4^*	1.5
C20:4 MAG	0.7^*	0.5^*
diacylglycerols (DAG)
C32:0 DAG	0.7^**	0.9
C34:2 DAG	0.4^**	0.8
C34:1 DAG	0.2^**	0.9
C36:4 DAG (C16:0/C20:4 DAG)	0.3^**	0.5^**
C38:5 DAG (C18:0/C20:4 DAG)	0.6^**	0.6^*
triacylglycerols (TAG)
C48:2 TAG	0.4^**	1.0
C50:2 TAG	0.4^**	1.2
C52:4 TAG	0.7^*	1.7
C52:3 TAG	0.7	1.2
C52:1 TAG	0.6^*	1.1
C54:5 TAG	0.6^**	1.0
C52:4 TAG	0.5^**	0.9
C54:3 TAG	0.5^**	0.9
C56:6 TAG	0.7	0.9
lysophosphatidyl choline (LPC)
C16:0 LPC	0.9	1.2
phosphatidylcholine (PC)
C34:1 PC	0.8	1.2
C36:1 PC	0.9	1.1
acyl carnitine
C16:0 acylcarnitine	1.2	0.9

p<0.05

^**

p<0.01 with >1.4-fold or <0.7-fold of control